Orion Biotechnology Canada Ltd. — Form D/A

Orion Biotechnology Canada Ltd. of OTTAWA, ONTARIO, Z4, a company, filed a Form D amendment with the SEC on 2021-06-22. The offering totals $15.0M, of which $5.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Rudolf BomDirectorOttawa, A6
Theresa Sheila FirestoneDirectorOttawa, A6
Thomas Sheila HechtDirectorOttawa, A6
Anatole Sheila KlepatskyDirectorOttawa, A6
Dmytro Sheila MartynenkoDirectorOttawa, A6
Jason Sheila BurkeExecutive OfficerOttawa, A6
John Sheila JussupExecutive OfficerOttawa, A6
Anatole Sheila KlepatskyExecutive OfficerOttawa, A6
Theresa FirestoneDirectorToronto, A6
Theresa FirestoneExecutive OfficerToronto, A6
John JussupExecutive OfficerOttawa, Ontario, Z4
Lonnel CoatsDirectorOttawa, A6
Anatolii KlepatskyDirectorOttawa, Ontario, Z4
Anatolii KlepatskyExecutive OfficerOttawa, Ontario, Z4
Jean ForcioneDirectorOttawa, Ontario, Z4
Katie HewittDirectorOttawa, A6
Praveen TyleDirectorEncinitas, CA
Praveen TyleExecutive OfficerEncinitas, CA
Bradford SmithDirectorOttawa, Ontario, Z4
Mark GroperDirectorOttawa, Ontario, Z4
Mark GroperExecutive OfficerOttawa, Ontario, Z4
Jason BurkeExecutive OfficerOttawa, Ontario, Z4
Jason William BurkeExecutive OfficerOttawa, A6
Jean William ForcioneExecutive OfficerOttawa, A6
John William JussupExecutive OfficerOttawa, A6

Other filings by this issuer (5)

FiledFormOfferingSold
2025-08-26D/A$15.0M$6.8M
2024-07-23D$5.0M$743K
2023-03-15D/A$15.0M$9.9M
2021-06-15D$15.0M$5.4M
2020-10-09D$605K

More